Quantum Pharmics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUANTUM PHARMICS, and what generic and branded alternatives to QUANTUM PHARMICS drugs are available?
QUANTUM PHARMICS has sixty-three approved drugs.
Summary for Quantum Pharmics
| US Patents: | 0 |
| Tradenames: | 25 |
| Ingredients: | 23 |
| NDAs: | 63 |
Drugs and US Patents for Quantum Pharmics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 072376-001 | Mar 15, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | LORAZ | lorazepam | TABLET;ORAL | 070200-001 | Aug 9, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 088529-001 | Oct 22, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 072432-001 | Apr 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 072375-001 | Mar 15, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | NYSTATIN | nystatin | TABLET;ORAL | 062525-001 | Oct 29, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Quantum Pharmics | LORAZ | lorazepam | TABLET;ORAL | 070201-001 | Aug 9, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
